Skip to main content
. Author manuscript; available in PMC: 2013 Jan 15.
Published in final edited form as: Spine (Phila Pa 1976). 2012 Jan 15;37(2):140–149. doi: 10.1097/BRS.0b013e3182276b2b

Table 2.

Area Under Curve subgroup results from the adjusted* as-treated Oswestry Disability Index (ODI) outcome analysis for the three significant treatment effect predictors (joint, martial status, baseline health trend) (Time weighted average 4 years treatment effects)

Predictors N Surgical
(n = 788)
Non-operative
(n = 404)
Treatment Effect(95% CI)

No Joint Problem 963 −37.9 (0.6) −23.3 (0.7) −14.6 (−16.3, −12.9)
Joint Problem 221 −30.8 (1.2) −20.5 (1.4) −10.3 (−13.4, −7.3)

     p-value <0.001 0.062 0.012

Married 835 −37.4 (0.6) −21.5 (0.8) −15.8 (−17.6, −14)
Divorced/Widowed 130 −33.1 (1.5) −21.6 (2) −11.5 (−15.7, −7.3)
Single 212 −36.2 (1.3) −28.5 (1.5) −7.7 (−10.9, −4.5)

     p-value 0.023 <0.001 <0.001

Problem getting better 179 −39.9 (1.5) −27.3 (1.3) −12.6 (−15.9, −9.3)
Problem staying about the same 534 −36.4 (0.8) −24.6 (0.9) −11.8 (−13.8, −9.7)
Problem getting worse 472 −34.8 (0.8) −18.9 (1.2) −15.9 (−18.5, −13.4)

     p-value 0.013 <0.001 0.032
*

Adjusted for age, gender, marital status, smoking status, race, compensation, herniation location, working status, stomach comorbidity, depression, othe**comorbidity, self-rated health trend, duration of most recent episode, treatment preference and baseline score (for SF-36 and ODI), and center.

Treatment effect is the difference between the surgical and non-operative mean change from baseline.

**

Other comorbidities include: stroke, diabetes, osteoporosis, cancer, fibromyalgia, cerebrospinal fluid leak, PTSD, alcohol, drug dependency, heart, lung, liver, kidney, blood vessel, nervous system, hypertension, migraine, anxiety, stomach, or bowel problems.